- Report
- November 2021
- 82 Pages
Europe
From €1425EUR$1,500USD£1,222GBP
- Report
- January 2020
- 1500 Pages
Global
From €2850EUR$3,000USD£2,444GBP
- Report
- November 2021
- 545 Pages
Global
From €3800EUR$4,000USD£3,259GBP
- Report
- November 2021
- 233 Pages
Global
From €2375EUR$2,500USD£2,037GBP
- Report
- November 2021
- 1165 Pages
Global
From €5700EUR$6,000USD£4,888GBP
- Report
- May 2023
- 147 Pages
Global
From €5699EUR$5,999USD£4,887GBP
- Book
- October 2020
- 640 Pages
- Book
- July 2010
- 328 Pages
- Book
- December 2019
- 400 Pages
- Book
- June 2023
- 336 Pages
The Genetic Code market is a subset of the Genomics industry that focuses on the study of genetic codes and their applications. It involves the analysis of the structure, function, and evolution of genes, as well as the identification of genetic variations and their effects on health and disease. The market is driven by advances in sequencing technology, which has enabled the rapid and cost-effective sequencing of genomes. This has enabled the development of new diagnostic tests, treatments, and therapies for a range of diseases. Additionally, the market is driven by the increasing demand for personalized medicine, which is tailored to the individual's genetic makeup.
Companies in the Genetic Code market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10X Genomics. Show Less Read more
